Early Responses to Intravitreal Ranibizumab in Typical Neovascular Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy

Figure 1

Changes in the best-corrected visual acuity (BCVA) for tAMD and PCV patients after intravitreal ranibizumab. The BCVA was determined using the Landolt C chart and was presented as decimal visual acuities. Diamonds with dashed lines: tAMD; squares with solid lines: PCV. Values represent means ± SEM.